(Wakefield, MA)- The Angel Fund for ALS Research has awarded $800,000 to UMass Chan Medical School to accelerate research into amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
The donation supports the work of two recognized leaders in ALS research: Robert H. Brown Jr., DPhil, MD, the Donna M. and Robert J. Manning Chair in Neuroscience and professor of neurology and Daryl Bosco, PhD, the Paul J. Dimare Chair in Neurodegenerative Disease and professor of neurology, along with their research colleagues at UMass Chan. A pioneer in the field of ALS research, Dr. Brown discovered the first gene linked to hereditary ALS and led the first clinical trial for ALS using gene therapy.
The Angel Fund for ALS Research has raised millions of dollars to support scientific research, clinical trials, and collaborative efforts aimed at ending ALS. Since its inception in 1997, the Angel Fund has contributed more than $10 million to ALS research, over $2 million in the last three years.